High circulating tumor DNA (ctDNA) concentration was associated with shorter progression free survival in patients with metastatic breast cancer

被引:0
|
作者
Yi, Hanbaek
Kim, Tae-Yong
Song, Myung Geun
Kim, Hwang-Phill
Kim, Tae-You
Kim, Jinyong
Lee, Dae-Won
Lee, Kyung-Hun
Im, Seock-Ah
机构
关键词
D O I
10.1158/1538-7445.SABCS23-PO2-13-11
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PO2-13-11
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Circulating tumor DNA (ctDNA) detection is associated with shorter progression-free survival in advanced melanoma patients
    Gabriella Taques Marczynski
    Ana Carolina Laus
    Mariana Bisarro dos Reis
    Rui Manuel Reis
    Vinicius de Lima Vazquez
    Scientific Reports, 10
  • [2] Circulating tumor DNA (ctDNA) detection is associated with shorter progression-free survival in advanced melanoma patients
    Marczynski, Gabriella Taques
    Laus, Ana Carolina
    dos Reis, Mariana Bisarro
    Reis, Rui Manuel
    Vazquez, Vinicius de Lima
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [3] Landscape of circulating tumor DNA (ctDNA) in metastatic breast cancer
    Davis, Andrew A.
    Jacob, Saya
    Gerratana, Lorenzo
    Shah, Ami N.
    Wehbe, Firas
    Katam, Neelima
    Zhang, Qiang
    Flaum, Lisa
    Siziopikou, Kalliopi
    Platanias, Leonidas C.
    Gradishar, William J.
    Behdad, Amir
    Cristofanilli, Massimo
    CANCER RESEARCH, 2020, 80 (04)
  • [4] Utility of circulating tumor DNA (ctDNA) to inform treatment of patients with metastatic breast cancer
    Linville, Laura Meili
    Canzoniero, Jenna VanLiere
    Too, Faith
    Lombardo, Alexandra
    Malwankar, Jui
    Mawalkar, Resham
    Haile, Meron
    Zandi, Lily
    Babu, Vidya
    Brown, Derek W.
    Xu, Chang
    Boyle, Patrick
    Pasquina, Lincoln W.
    Santa-Maria, Cesar Augusto
    Tao, Jessica
    Bayable, Asnakech
    Greenberg, Larisa
    Anagnostou, Valsamo
    Stearns, Vered
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Detection of progression or regression of breast cancer by circulating tumor DNA (ctDNA)
    Karki, Ujjwal
    Ghimire, Bipin
    Herrman, Emma
    Yadav, Siddhartha
    Chisti, Mohammad Muhsin
    CANCER RESEARCH, 2023, 83 (05)
  • [6] Circulating Tumor DNA and Survival in Metastatic Breast Cancer
    Dickinson, Kyle
    Sharma, Archi
    Agnihotram, Ramana-Kumar Venkata
    Altuntur, Selin
    Park, Morag
    Meterissian, Sarkis
    Burnier, Julia V.
    JAMA NETWORK OPEN, 2024, 7 (09)
  • [7] Clinical utility of circulating tumor DNA (ctDNA) in advanced and metastatic breast cancer
    Austin, Laura K.
    Jaslow, Rebecca
    Avery, Tiffany
    Fortina, Paolo
    Sebisanovic, Dragan
    Siew, LaiMun
    Zapanta, Aubrey
    Talasaz, AmirAli
    Cristofanilli, Massimo
    CANCER RESEARCH, 2015, 75
  • [8] Detection of Circulating Tumor Cells Prior to Autologous Stem Cell Transplantation Is Predictive of Shorter Progression Free Survival in Metastatic Breast Cancer
    Gao, H.
    Lee, B-N
    Cohen, E. N.
    Mego, M.
    Davis, M. L.
    Giordano, A.
    Cristofanilli, M.
    Ueno, N. T.
    Reuben, J. M.
    CANCER RESEARCH, 2010, 70
  • [9] Genomic progression, detected by circulating tumor DNA (ctDNA) sequencing, as an early predictor of disease progression in metastatic breast cancer (MBC)
    Velimirovic, M.
    Juric, D.
    Niemierko, A.
    Spring, L. M.
    Vidula, N.
    Malvarosa, G.
    Yuen, M.
    Moy, B.
    Isakoff, S. J.
    Ellisen, L. W.
    Bardia, A.
    CANCER RESEARCH, 2019, 79 (04)
  • [10] Genomic profiling of circulating tumor DNA (ctDNA) from patients (pts) with metastatic breast cancer (mBC).
    Pusztai, Lajos
    Chung, Jon
    Young, Lauren
    Schrock, Alexa Betzig
    Hartmaier, Ryan
    Frampton, Garrett Michael
    Gay, Laurie M.
    Stephens, Phil
    Miller, Vincent A.
    Ali, Siraj Mahamed
    Ross, Jeffrey S.
    Vahdat, Linda T.
    O'Shaughnessy, Joyce
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35